Prophylactic thyroid surgery;Prophylaktische chirurgie der schilddrüse

Chirurg

Volumn 77, Issue 1, 2006, Pages 6-14

  Frilling, A ^a   Weber, F ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Codon oriented prophylactic surgery; Medullar thyroid carcinoma

Indexed keywords

PROTEIN RET; RET PROTEIN, HUMAN;

ADOLESCENT; ADULT; CELL TRANSFORMATION; CHILD; CODON; EARLY DIAGNOSIS; GENETIC SCREENING; GENETICS; GENOTYPE; HUMAN; INFANT; MEDULLARY CARCINOMA; MORTALITY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHENOTYPE; PRESCHOOL CHILD; REVIEW; RISK ASSESSMENT; SIPPLE SYNDROME; THYROID GLAND; THYROID TUMOR; THYROIDECTOMY;

ADOLESCENT; ADULT; CARCINOMA, MEDULLARY; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; CODON; DNA MUTATIONAL ANALYSIS; EARLY DIAGNOSIS; GENETIC SCREENING; GENOTYPE; HUMANS; INFANT; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-RET; RISK ASSESSMENT; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 31144443745     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-005-1118-7     Document Type: Review

References (35)

1. Alsanea O (2000) Familial nonmedullary thyroid cancer. Curr Treat Options Oncol 1:345-351
2. Attie T, Pelet A, Edery P et al. (1995) Diversity of proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet 4:1381-1386
3. Brandi ML, Gagel RF, Angeli A et al. (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658-5671
4. Brauckhoff M, Gimm O, Hinze R, Ukkat J, Brauckhoff K, Dralle H (2002) Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutation. Thyroid 12:557-561
5. Brauckhoff M, Gimm O, Weiss C-L et al. (2004) Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease. World J Surg 28:1305-1311
6. Carlson KM, Bracamontes J, Jackson CE, Clark R (1994) Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am J Hum Genet 55:1076-1082
7. Carlson KM, Dou S, Chi D et al. (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 91:1579-1583
8. Decker RA, Peacock ML, Watson P (1998) Hirschsprung disease in MEN 2A: increased spectrum of RET Exon 10 genotypes and strong genotype-phenotype correlation. Hum Mol Genet 7:129-134
9. Donis-Keller H, Dou S, Chi D et al. (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2:851-856
10. Dralle H, Gimm O, Simon D et al. (1998) Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg 22:744-751
11. Dralle H, Damm I, Scheumann GF et al. (2004) Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 24:112-121
12. Eng C (1996) Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease. N Engl J Med 335:943-951
13. Eng C, Clayton D, Schuffenecker I et al. (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. Jama 276:1575-1579
14. Fitze G (2004) Management of patients with hereditary medullary thyroid carcinoma. Eur J Pediatr Surg 14:375-383
15. Frilling A, Röher H-D, Ponder BAJ (1994) Presymptomatic screening for medullary thyroid carcinoma in patients with multiple endocrine neoplasia type 2A. World J Surg 18:577-582
16. Frilling A, Dralle H, Eng C, Raue F, Broelsch CE (1995) Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Surgery 118:1099-1104
17. Gibelin H, Bezieau S, Misso C, Bouin-Pineau MH, Marechaud R, Kraimps JL (2004) Germline RET V804 M mutation associated with multiple endocrine neoplasia type 2A. Br J Surg 91:1458-1459
18. Gimm O, Marsh DJ, Andrew SD et al (1997) Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab 82:3902-3904
19. Hansford JR, Mulligan LM (2000) Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet 37:817-827
20. Haveman JW, van Tol KM, Rouwe CW, Piers do A, Plukker JT (2003) Surgical experience in children with differentiated thyroid carcinoma. Ann Surg Oncol 10:15-20
21. Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1998) A national cancer data base report on 53.856 cases of thyroid carcinoma treated in the U.S. 1985-1995. Cancer 83:2638-2648
22. Lips CJM, Landsvater RM, Höppener JWM et al. (1994) Clinical screening as compared with DNA anlysis in families with multiple nedocrine neoplasia type 2A. N Engl J Med 331:828-835
23. Machens A, Niccoli-Sire P, Hoegel J et al. (2003) Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349:1517-1525
24. Machens A, Ukkat J, Brauckhoff M, Gimm O, Dralle H (2005) Advances in the management of hereditary medullary thyroid cancer. J Intern Med 257:50-59
25. Mathew CG, Chin KS, Easton DF et al. (1987) A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328:527-528
26. Mulligan LM, Kwok JB, Healey CS et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460
27. Nagy R, Sweet K, Eng C (2004) Highly penetrant hereditary cancer syndromes. Oncogene 23(38):6445-6470
28. Niccoli-Sire P, Murat A, Rohmer V et al. (2003) When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations? Surgery 134:1029-1037
29. Robledo M, Gil L, Pollan M et al. (2003) Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A. Cancer Res 63:1814-1817
30. Simpson NE, Kidd KK, Goodfellow PJ, McDermid H et al. (1987) Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 328:528-530
31. Takahashi M, Ritz J, Cooper GM (1985) Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42:581-588
32. Weber F, Eng C (2005) Gene expression profiling in differentiated thyroid cancer - A viable strategy for the practice of genomic medicine? Future Oncol (in press)
33. Weber F, Shen L, Aldred MA et al. (2005) Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. J Clin Endocrinol Metab 90:2512-2521
34. Wells SA Jr, Chi DD, Toshima K et al. (1994) Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 220:237-250
35. Yip L, Cote GJ, Shapiro SE et al. (2003) Multiple endocrine neoplasia type 2: Evaluation of the genotype-phenotype relationship. Arch Surg 138:409-416